Change From Baseline in Urine Protein Excretion (24 Hour)-Part 1: GSK2857916 2.50 mg/kg
Dose Escalation Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, Immunogenicity and Clinical Activity of GSK2857916 · Source last updated 2020-08-11
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
Measure
MEAN
Unit
Grams per day
Interval / dispersion
Standard Deviation
Time frame
Baseline and Day 1 (Cycle 2, 3, 4, 5, 6, 7, 8, 10, 12, 13, 14, 15, 16)
What was measured
Urine samples were collected to assess urine Pro. Baseline was the latest pre-dose assessment with a non-missing value, including unscheduled visits. Change from Baseline was calculated by subtracting Baseline value from the post-dose visit value. Data for change from Baseline in urine Pro. excretion (24 hour) is presented
Analysis population: Part 1 Population. Only those participants with data available at the specified data points were analyzed (represented by n=X in the category titles). NA indicates that standard deviation could not be calculated for a single participant.
Groups in this outcome
Part 1: GSK2857916 2.50 mg/kg
Participants were administered a dose of 2.50 mg/kg GSK2857916 as IV infusion once every three weeks for a maximum of 16 cycles (1 cycle= 21 days).
Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.
Analysis denominator · Participants
Group
Source count
Part 1: GSK2857916 2.50 mg/kg
8
Reported measurements
Day 1 (Cycle 2), n=4
Analysis denominator · Participants
Group
Source count
Part 1: GSK2857916 2.50 mg/kg
4
Values in Grams per day · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Part 1: GSK2857916 2.50 mg/kg
0.8
1.54
Not reported
Not reported
Not reported
Day 1 (Cycle 3), n=2
Analysis denominator · Participants
Group
Source count
Part 1: GSK2857916 2.50 mg/kg
2
Values in Grams per day · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Part 1: GSK2857916 2.50 mg/kg
-0.2
0.31
Not reported
Not reported
Not reported
Day 1 (Cycle 4), n=2
Analysis denominator · Participants
Group
Source count
Part 1: GSK2857916 2.50 mg/kg
2
Values in Grams per day · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Part 1: GSK2857916 2.50 mg/kg
-0.2
0.38
Not reported
Not reported
Not reported
Day 1 (Cycle 5), n=1
Analysis denominator · Participants
Group
Source count
Part 1: GSK2857916 2.50 mg/kg
1
Values in Grams per day · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Part 1: GSK2857916 2.50 mg/kg
0.0
NA
Not reported
Not reported
NA indicates that standard deviation could not be calculated for a single participant.
Day 1 (Cycle 6), n=2
Analysis denominator · Participants
Group
Source count
Part 1: GSK2857916 2.50 mg/kg
2
Values in Grams per day · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Part 1: GSK2857916 2.50 mg/kg
-0.2
0.33
Not reported
Not reported
Not reported
Day 1 (Cycle 7), n=1
Analysis denominator · Participants
Group
Source count
Part 1: GSK2857916 2.50 mg/kg
1
Values in Grams per day · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Part 1: GSK2857916 2.50 mg/kg
0.2
NA
Not reported
Not reported
NA indicates that standard deviation could not be calculated for a single participant.
Day 1 (Cycle 8), n=1
Analysis denominator · Participants
Group
Source count
Part 1: GSK2857916 2.50 mg/kg
1
Values in Grams per day · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Part 1: GSK2857916 2.50 mg/kg
-0.5
NA
Not reported
Not reported
NA indicates that standard deviation could not be calculated for a single participant.
Day 1 (Cycle 10), n=1
Analysis denominator · Participants
Group
Source count
Part 1: GSK2857916 2.50 mg/kg
1
Values in Grams per day · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Part 1: GSK2857916 2.50 mg/kg
-0.4
NA
Not reported
Not reported
NA indicates that standard deviation could not be calculated for a single participant.
Day 1 (Cycle 12), n=1
Analysis denominator · Participants
Group
Source count
Part 1: GSK2857916 2.50 mg/kg
1
Values in Grams per day · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Part 1: GSK2857916 2.50 mg/kg
-0.5
NA
Not reported
Not reported
NA indicates that standard deviation could not be calculated for a single participant.
Day 1 (Cycle 13), n=1
Analysis denominator · Participants
Group
Source count
Part 1: GSK2857916 2.50 mg/kg
1
Values in Grams per day · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Part 1: GSK2857916 2.50 mg/kg
-0.5
NA
Not reported
Not reported
NA indicates that standard deviation could not be calculated for a single participant.
Day 1 (Cycle 14), n=1
Analysis denominator · Participants
Group
Source count
Part 1: GSK2857916 2.50 mg/kg
1
Values in Grams per day · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Part 1: GSK2857916 2.50 mg/kg
-0.4
NA
Not reported
Not reported
NA indicates that standard deviation could not be calculated for a single participant.
Day 1 (Cycle 15), n=1
Analysis denominator · Participants
Group
Source count
Part 1: GSK2857916 2.50 mg/kg
1
Values in Grams per day · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Part 1: GSK2857916 2.50 mg/kg
-0.5
NA
Not reported
Not reported
NA indicates that standard deviation could not be calculated for a single participant.
Day 1 (Cycle 16), n=1
Analysis denominator · Participants
Group
Source count
Part 1: GSK2857916 2.50 mg/kg
1
Values in Grams per day · Interval/dispersion: Standard Deviation
Group
Value
Spread
Lower
Upper
Comment
Part 1: GSK2857916 2.50 mg/kg
-0.5
NA
Not reported
Not reported
NA indicates that standard deviation could not be calculated for a single participant.
Complete source fields
classes
categories
measurements
group Id
OG000
spread
1.54
value
0.8
denoms
counts
group Id
OG000
value
4
units
Participants
title
Day 1 (Cycle 2), n=4
categories
measurements
group Id
OG000
spread
0.31
value
-0.2
denoms
counts
group Id
OG000
value
2
units
Participants
title
Day 1 (Cycle 3), n=2
categories
measurements
group Id
OG000
spread
0.38
value
-0.2
denoms
counts
group Id
OG000
value
2
units
Participants
title
Day 1 (Cycle 4), n=2
categories
measurements
comment
NA indicates that standard deviation could not be calculated for a single participant.
group Id
OG000
spread
NA
value
0.0
denoms
counts
group Id
OG000
value
1
units
Participants
title
Day 1 (Cycle 5), n=1
categories
measurements
group Id
OG000
spread
0.33
value
-0.2
denoms
counts
group Id
OG000
value
2
units
Participants
title
Day 1 (Cycle 6), n=2
categories
measurements
comment
NA indicates that standard deviation could not be calculated for a single participant.
group Id
OG000
spread
NA
value
0.2
denoms
counts
group Id
OG000
value
1
units
Participants
title
Day 1 (Cycle 7), n=1
categories
measurements
comment
NA indicates that standard deviation could not be calculated for a single participant.
group Id
OG000
spread
NA
value
-0.5
denoms
counts
group Id
OG000
value
1
units
Participants
title
Day 1 (Cycle 8), n=1
categories
measurements
comment
NA indicates that standard deviation could not be calculated for a single participant.
group Id
OG000
spread
NA
value
-0.4
denoms
counts
group Id
OG000
value
1
units
Participants
title
Day 1 (Cycle 10), n=1
categories
measurements
comment
NA indicates that standard deviation could not be calculated for a single participant.
group Id
OG000
spread
NA
value
-0.5
denoms
counts
group Id
OG000
value
1
units
Participants
title
Day 1 (Cycle 12), n=1
categories
measurements
comment
NA indicates that standard deviation could not be calculated for a single participant.
group Id
OG000
spread
NA
value
-0.5
denoms
counts
group Id
OG000
value
1
units
Participants
title
Day 1 (Cycle 13), n=1
categories
measurements
comment
NA indicates that standard deviation could not be calculated for a single participant.
group Id
OG000
spread
NA
value
-0.4
denoms
counts
group Id
OG000
value
1
units
Participants
title
Day 1 (Cycle 14), n=1
categories
measurements
comment
NA indicates that standard deviation could not be calculated for a single participant.
group Id
OG000
spread
NA
value
-0.5
denoms
counts
group Id
OG000
value
1
units
Participants
title
Day 1 (Cycle 15), n=1
denoms
counts
group Id
OG000
value
8
units
Participants
description
Urine samples were collected to assess urine Pro. Baseline was the latest pre-dose assessment with a non-missing value, including unscheduled visits. Change from Baseline was calculated by subtracting Baseline value from the post-dose visit value. Data for change from Baseline in urine Pro. excretion (24 hour) is presented
dispersion Type
Standard Deviation
groups
description
Participants were administered a dose of 2.50 mg/kg GSK2857916 as IV infusion once every three weeks for a maximum of 16 cycles (1 cycle= 21 days).
id
OG000
title
Part 1: GSK2857916 2.50 mg/kg
param Type
MEAN
population Description
Part 1 Population. Only those participants with data available at the specified data points were analyzed (represented by n=X in the category titles). NA indicates that standard deviation could not be calculated for a single participant.
reporting Status
POSTED
time Frame
Baseline and Day 1 (Cycle 2, 3, 4, 5, 6, 7, 8, 10, 12, 13, 14, 15, 16)
title
Change From Baseline in Urine Protein Excretion (24 Hour)-Part 1: GSK2857916 2.50 mg/kg